Learn more about Pfizer and BioNTech’s clinical trial for an investigational COVID-19 and flu vaccine using mRNA technology
Researchers are testing an investigational medicine for COVID-19. They want to know how well it may work and if it is safe in adults with COVID-19 who are at a higher risk for severe illness from COVID-19.
One and done: Help make dual protection against COVID-19 and flu possible with a combination vaccine
Help make dual protection against COVID-19 and flu possible with a combination vaccine
Join a clinical study testing the effects of an investigational oral drug on blood pressure.
TRAILRUNNER-ALZ 3 is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine may help treat people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease.
The GN01 study is a new clinical research study from Eli Lilly and Company. It will test if an investigational medicine (a medicine being studied) is safe and could reduce weight in people with obesity or overweight.
To be eligible for the study, you must be diagnosed with RSV and enrolled within 3 days of your symptoms starting.
This study will investigate the safety and efficacy of a new investigational medicine in adults who are living with obesity or excess weight with at least one weight-related medical condition (such as cardiovascular disease (CVD) or high blood pressure).
This study is evaluating an oral investigational medication (solriamfetol) in adults with BED. Solriamfetol is approved by the FDA for people who have excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea (OSA), which are sleep-related disorders. Solriamfetol is an investigational treatment for BED, meaning it has not yet been approved by any health authority for the treatment of BED.
Controlled Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants with Obesity or Overweight
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)